MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
企業コードMDXG
会社名MiMedx Group Inc
上場日Aug 20, 2007
最高経営責任者「CEO」Mr. Joseph H. (Joe) Capper
従業員数837
証券種類Ordinary Share
決算期末Aug 20
本社所在地1775 W Oak Commons Court, Ne
都市MARIETTA
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号30062
電話番号17706519100
ウェブサイトhttps://mimedx.com/
企業コードMDXG
上場日Aug 20, 2007
最高経営責任者「CEO」Mr. Joseph H. (Joe) Capper
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし